Menu

Omega Therapeutics, Inc. OMGA

Full chart Compare
Set alert

Price alert · OMGA

All alert types
0.14 USD 0.00 (+0.00%)

At closeFeb 24, 2025, 4:00 PM EST

0.1426 Day range 0.166
0.75 52-week range 6.30
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $68.70MExpenses → Gross Loss: $62.77MExpenses → Selling, General & Admin: $26.19MExpenses → Research & Development: $77.17MNet Loss → Expenses: $97.43MRevenue → Cost of Revenue: $3.09MOther Income$68.70MNet Loss$97.43MCost of Revenue$65.87MExpenses$166.13MGross Loss$62.77MSelling, General & Admin$26.19MResearch & Development$77.17MRevenue$3.09M

Latest period ending Dec 31, 2023 · select a line to chart its full history

OMGA annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
3.09M2.07M144.00K00
3.09M2.07M144.00K00
-100.26M-102.77M-66.03M-28.67M-17.33M
-97.43M-102.70M-68.28M-29.45M-17.95M
-1.80-2.14-3.05-7.54-1.43
OMGA annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
68.78M70.96M186.82M23.29M2.62M
204.37M146.00M233.33M28.08M6.12M
146.35M40.03M32.70M17.49M15.33M
128.43M22.58M19.87M11.73M11.89M
58.02M105.97M200.63M-64.63M-35.92M
OMGA annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-91.51M-98.52M-57.61M-26.13M-15.68M
47.52M-18.06M-40.40M-1.81M-885.00K
41.82M708.00K261.54M48.62M11.98M
-2.22M-1.38M-1.47M-1.81M-885.00K
-2.17M-115.87M163.53M20.68M-4.58M